Till Bärnighausen is the Director of the Heidelberg Institute of Global Health (HIGH). He is also the Alexander von Humboldt Professor at the University of Heidelberg and Senior Faculty at one of the five Global Programs of the British Welcome Trust, the Africa Health Research Institute (AHRI) in South Africa. His research focuses on identifying, designing and testing novel interventions to boost population health, addressing prevention and treatment needs for major diseases such as HIV, diabetes, hypertension and depression. He was trained as a medical doctor and is a consultant and clinical specialist in Family Medicine. He previously worked as a Family Medicine doctor in Germany, China and South Africa, and as a management consultant for McKinsey & Company. Before taking the lead at HIGH, he was a faculty at Harvard T.H. Chan School of Public Health. He holds doctoral degrees in International and Population Health (Harvard University, USA) and History of Medicine (Heidelberg University, Germany), as well as master’s degrees in Health Systems Management (LSH&TM, UK), Financial Economics (SOAS, UK), and Innovation and Entrepreneurship (HEC Paris, France). He has published more than 550 peer-reviewed articles, including in Science, PNAS, Science Translational Medicine, Lancet, Lancet Global Health, JAMA, JAMA Internal Medicine, PLOS Medicine, and BMJ.
